CURCUMIN: THE INDIAN SOLID GOLD

P1: OTE/SPH P2: OTE
SVNY332-Aggarwal December 22, 2006 16:34
CURCUMIN: THE INDIAN SOLID GOLD 41
chemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and
7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis
17, 1305–1311 (1996).
428. M. J. Wargovich, C. D. Chen, A. Jimenez, V. E. Steele, M. Velasco, L. C. Stephens, R.
Price, K. Gray, and G. J. Kelloff, Aberrant crypts as a biomarker for colon cancer: evaluation
of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers
Prev 5, 355–360 (1996).
429. H. S. Samaha, G. J. Kelloff, V. Steele, C. V. Rao, and B. S. Reddy, Modulation of
apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl
isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and
promotion. Cancer Res 57, 1301–1305 (1997).
430. T. Kawamori, R. Lubet, V. E. Steele, G. J. Kelloff, R. B. Kaskey, C. V. Rao, and B. S.
Reddy, Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory
agent, during the promotion/progression stages of colon cancer. Cancer Res 59, 597–
601 (1999).
431. C. V. Rao, T. Kawamori, R. Hamid, and B. S. Reddy, Chemoprevention of colonic
aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis
20, 641–644 (1999).
432. Y. Kwon, M. Malik, and B. A. Magnuson, Inhibition of colonic aberrant crypt foci by
curcumin in rats is affected by age. Nutr Cancer 48, 37–43 (2004).
433. S. R. Volate, D. M. Davenport, S. J. Muga, and M. J. Wargovich, Modulation of
aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin,
silymarin, ginseng and rutin). Carcinogenesis 26, 1450–1456 (2005).
434. J. M. Kim, S. Araki, D. J. Kim, C. B. Park, N. Takasuka, H. Baba-Toriyama, T. Ota,
Z. Nir, F. Khachik, N. Shimidzu, Y. Tanaka, T. Osawa, T. Uraji, M. Murakoshi, H.
Nishino, and H. Tsuda, Chemopreventive effects of carotenoids and curcumins on
mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis
19, 81–85 (1998).
435. R. Hanif, L. Qiao, S. J. Shiff, and B. Rigas, Curcumin, a natural plant phenolic food
additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma
cell lines by a prostaglandin-independent pathway. J Lab Clin Med 130,
576–584 (1997).
436. H. Chen, Z. S. Zhang, Y. L. Zhang, and D. Y. Zhou, Curcumin inhibits cell proliferation
by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells.
Anticancer Res 19, 3675–3680 (1999).
437. R. Rashmi, T. R. Santhosh Kumar, and D. Karunagaran, Human colon cancer cells
differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them
by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett 538,
19–24 (2003).
438. G. P. Collett and F. C. Campbell, Curcumin induces c-jun N-terminal kinase-dependent
apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25, 2183–2189
(2004).
439. S. C. Wei, Y. S. Lin, P. N. Tsao, J. J. Wu-Tsai, C. H. Wu, and J. M. Wong, Comparison
of the anti-proliferation and apoptosis-induction activities of sulindac, celecoxib,
curcumin, and nifedipine in mismatch repair-deficient cell lines. J Formos Med Assoc
103, 599–606 (2004).
440. G. Song, Y. B. Mao, Q. F. Cai, L. M. Yao, G. L. Ouyang, and S. D. Bao, Curcumin
induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and
regulating apoptosis-related protein expression. Braz J Med Biol Res 38, 1791–1798
(2005).